{
    "lc_text": {
       "description": "In this task, read the given text and then answer the given questions. Spend approximately 10 mins per task."
    },
    "lc_viz": {
        "description": "In this task, interpret the visualization and then answer the given questions. Spend approximately 10 mins per task."
    },
    "termsboard_text": {
        "description": "In this task, based on the given list of documents, write a report about a given topic. Spend approximately 20 mins per task."
     },
    "termsboard_viz": {
        "description": "In this task, based on the given list of documents and termsboard visualization, write a report about a given topic. Spend approximately 20 mins per task."
     },
    "lc": {
        "case1": {
            "title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds",
            "key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds",
            "date": "2020-04-21 00:00:00",
            "link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds"
        },
        "case2": {
            "title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19",
            "key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19",
            "date": "2020-08-20 00:00:00",
            "link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19"
        }, 
        "case3": {
            "title": "Challenges expected for Novavax COVID-19 vaccine in USA",
            "key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa",
            "date": "2021-06-23 00:00:00",
            "link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa"
        },
        "case4": {
            "title": "Japan is first country to approve COVID-19 cocktail Ronapreve",
            "key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve",
            "date": "2021-07-20 00:00:00",
            "link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve"
        }
    },
    "termsboard": {
        "case1": {
            "title": "Write a report on Pfizer based of the provided information",
            "key": "pfizer"
        },
        "case2": {
            "title": "Write a report on Astrazeneca based of the provided information",
            "key": "astrazeneca"
        }
    }
}